65,437 trials
Airway Management
Primary: The Primary Outcome Measure Was the Complication Rate Asssed as the Number of Participants Causing Injuries — 6; 18; 17; 6 Participants — p=0.001
Adenomatous Polyp · Colorectal Cancer · Obesity
Primary: Change in Activated S6serine235 (i.e., the Ratio of pS6serine235/S6serine235) — 0.0228 weighted ratio of staining cells — p=> 0.773
Gastric or Duodenal Ulcers
Primary: Frequency of Adverse Drug Reactions — 1; 1; 1; 1 participants
Birch Pollen Allergy
Primary: Average of the Combined Rhinoconjunctivitis Symptom and Medication Score (RSMS) Obtained Daily During the Birch Pollen Season — 0.853; 0.795; 0.959 units on a scale
Peripheral Arterial Disease · Claudication
Primary: Major Adverse Event Rate — 1.3 percentage of participants
Sleep Apnea, Obstructive
Primary: Therapy Adherence With Treatment Per Night Averaged Over Total Time Period Measured Via Internal Software on the Device and Reported on Using InfoSmart™ Software With…
Heartburn
Primary: Area Under the Curve (AUC(0 to Infinity)) Following Single Dose Administration of Famotidine/Antacid Combination EZ Chew Without Water and Famotidine/Antacid Tablet With…
Lipid Metabolism, Inborn Errors · Hyperlipidemias · Metabolic Diseases
Primary: Change From Baseline in Liver Triglyceride (TG) Content As Measured by Magnetic Resonance Spectroscopy (MRS) — 0.2; 1.2; 6.4; 0.8 percentage of total liver content…
Opioid-Related Disorders · Opiate Dependence
Primary: Retention in Treatment in the Per Protocol Population — 113; 122 participants — p=<0.05
Multiple Myeloma
Primary: Best Response — 56; 17; 10 participants
Robot-Assisted Laparoscopic Radical Prostatectomy
Primary: Maximum Intraocular Pressure During RALRP Under Deep Neuromuscular Blockade — 23.3; 19.8 mmHg
Gastroesophageal Reflux Disease (GERD)
Primary: Percentage of Participants With Erosive Gastroesophageal Reflux Disease (eGERD) Who Achieved Endoscopically-confirmed Healing by 8 Weeks — 87.8; 88.2; 6.3; 5.9…
Asthma
Primary: Weekly Mean Combined Daytime Asthma Symptom Score — -0.456; -0.535; -0.504 units on a scale — p=0.4963
Moderate to Severe Nasolabial Folds
Primary: Investigator Assessment of Nasolabial Fold Severity Using the 5-point Nasolabial Fold Severity Scale (NLFSS) — 2.8; 2.8 Scores on a Scale
Schizoaffective Disorder · Schizophrenia · Affective Psychosis, Bipolar
Primary: Number of Cigarettes Smoked Per Day — 15.4; 14.9 number of cigarettes — p=0.489